The surgical treatment of urolithiasis has undergone a marked evolution over the past 30 years.
A new study has found that vitamin D supplementation does not appear to contribute to an elevated risk for kidney stones.
It is common for patients who suffer their first urinary stone to experience subsequent stone episodes.
New findings show that urinary biochemical composition changes with age.
New study suggests that emergency bedside ultrasound suffices for stones smaller than 6 mm.
Patients treated with percutaneous nephrolithotomy had a 79% increased risk of diabetes compared with those treated with extracorporeal shockwave lithotripsy.
The DASH diet might be an effective alternative to the low-oxalate diet.
Study of emergency department visits for renal colic at a New York hospital links the findings to average monthly temperature.
Even modest activity is beneficial, researchers report.
Common genetic polymorphisms may explain patterns in vitamin D status in blacks.
Study reveals 36% increased risk among women and 22% increased risk among men.
It may reduce urinary citrate excretion, which is associated with an elevated stone risk, according to researchers.
The drug, which was off the market for the past year and a half, is indicated for the dissolution of renal and vesical calculi of the apatite or struvite variety.
A serum 25-hydroxyvitamin D level of 20 to 100 ng/mL has no significant association with kidney stone incidence.
Study reveals high stone-free rate and low complication rate.
Low HDL or high triglyceride levels were associated with significantly higher urinary sodium, oxalate, and uric acid levels, as well as lower urinary pH.
Patients missed fewer days of work after undergoing medical expulsive therapy than after having early endoscopic stone removal.
The test was ordered for only about 8% of patients at high risk for urinary stone recurrence.